MNKD


MannKind Corporation (MNKD): Short-Term Outlook, Long-Term Drivers

MannKind Corporation (NASDAQ:MNKD) has had a bit of a hard time over the past few months. However, about 2 weeks ago, that all …

Company Update (NASDAQ:MNKD): James S. Shannon Rejoins MannKind Corporation’s Board of Directors

MannKind Corporation (NASDAQ:MNKD) announced that James S. Shannon, MD, MRCP (UK) has been elected to the company’s Board of Directors after previously serving …

MannKind Corporation (MNKD) Stock, Another Buying Opportunity

­ MannKind Corporation (NASDAQ:MNKD) Throughout the past few months, MannKind has had a relatively rough time in the market. Starting with a downgrade …

Can The Bull Run Continue For MannKind Corporation (MNKD)?

­ MannKind Corporation (NASDAQ:MNKD) MannKind stock has had a great beginning to the week so far. After a strong Friday, the gains continued …

Tuesday Pre-Market Insights: MannKind Corporation (MNKD), Achillion Pharmaceuticals, Inc. (ACHN), Etsy Inc (ETSY), Opko Health Inc. (OPK)

MannKind Corporation (NASDAQ:MNKD) shares increased approximately 4.5% in pre-market trading to $4.

MannKind Corporation (MNKD) Stock Climbs On Physician Feedback

­ MannKind Corporation (NASDAQ:MNKD) Following the recent declines that we’ve seen from the stock, MannKind is having a great day in the market …

MannKind Corporation (MNKD): Afrezza Prescriptions Picking Up

MannKind Corporation (NASDAQ:MNKD) released its latest earnings report on May 8, and Wall Street was generally disappointed. However, not everyone is so bearish …

J.P. Morgan Raises Red Flag on MannKind Corporation

Shares of MannKind Corporation (NASDAQ:MNKD) were hammered today after J.P.

MannKind Corporation Disappoints with Afrezza Sales; Analysts Lower Expectations

MannKind Corporation (NASDAQ:MNKD) reported first quarter 2015 results on May 7, revealing underwhelming sales and a mediocre Afrezza launch. Shares of MannKind last …

Piper Jaffray Slashes Price Target for MannKind Corporation on Back of Financial Position Concerns

In a research report issued Friday, Piper Jaffray analyst Joshua Schimmer maintained a Neutral rating on MannKind Corporation (NASDAQ:MNKD) and reduced the price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts